Stunning presentation.
Looks like massive delays with the GBM trial. Reworking the whole design to include IV delivery for first dose and adding in chemo.
Disappointed we won't see any further GBM results for a long time (probably 2026), especially since the data to date has been so compelling.
CDH17 now officially the lead candidate. The cohort patient numbers are not at all clear. I take it 15 patients is all dose escalation. And then dose expansion - will they make up the phase 2 patient numbers?
- Forums
- ASX - By Stock
- Ann: Investor Presentation
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.5¢

Stunning presentation. Looks like massive delays with the GBM...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.068M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
19 | 12882293 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 17149687 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 12882293 | 0.004 |
36 | 26384271 | 0.003 |
17 | 16400505 | 0.002 |
12 | 54150000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 17149687 | 17 |
0.006 | 11718229 | 12 |
0.007 | 3350000 | 3 |
0.008 | 8685291 | 7 |
0.009 | 1149101 | 3 |
Last trade - 12.52pm 02/07/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
Day chart unavailable
The Watchlist
RAC
RACE ONCOLOGY LTD
Dr Pete Smith, Executive Chairman
Dr Pete Smith
Executive Chairman
SPONSORED BY The Market Online